Semisynthetic modifications of hemiaminal function at ornithine unit of mulundocandin, towards chemical stability and antifungal activity (Q44646726)

From Wikidata

Jump to navigation Jump to search

scientific article published on November 17, 2003

edit

Language	Label	Description	Also known as
English	Semisynthetic modifications of hemiaminal function at ornithine unit of mulundocandin, towards chemical stability and antifungal activity	scientific article published on November 17, 2003

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14604682

retrieved

5 December 2017

title

Semisynthetic modifications of hemiaminal function at ornithine unit of mulundocandin, towards chemical stability and antifungal activity (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14604682

retrieved

5 December 2017

main subject

organic chemistry

1 reference

stated in

Crossref

DOI

10.1016/J.BMC.2003.08.003

reference URL

https://api.crossref.org/works/10.1016/J.BMC.2003.08.003

retrieved

29 March 2024

pharmaceutical science

1 reference

stated in

Crossref

DOI

10.1016/J.BMC.2003.08.003

reference URL

https://api.crossref.org/works/10.1016/J.BMC.2003.08.003

retrieved

29 March 2024

molecular medicine

1 reference

stated in

Crossref

DOI

10.1016/J.BMC.2003.08.003

reference URL

https://api.crossref.org/works/10.1016/J.BMC.2003.08.003

retrieved

29 March 2024

biochemistry

1 reference

stated in

Crossref

DOI

10.1016/J.BMC.2003.08.003

reference URL

https://api.crossref.org/works/10.1016/J.BMC.2003.08.003

retrieved

29 March 2024

author name string

Bansi Lal

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14604682

retrieved

5 December 2017

Vitthal Genbhau Gund

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14604682

retrieved

5 December 2017

Ashok Kumar Gangopadhyay

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14604682

retrieved

5 December 2017

Vidula Dikshit

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14604682

retrieved

5 December 2017

S. R. Nadkarni

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14604682

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14604682

retrieved

29 March 2024

D. K. Chatterjee

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14604682

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14604682

retrieved

29 March 2024

R. Shirvaikar

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14604682

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14604682

retrieved

29 March 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14604682

retrieved

5 December 2017

17 November 2003

1 reference

stated in

National Center for Biotechnology Information

PubMed publication ID

14604682

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14604682

retrieved

29 March 2024

full work available at URL

https://api.elsevier.com/content/article/PII:S0968089603005509?httpAccept=text/xml

1 reference

stated in

Crossref

DOI

10.1016/J.BMC.2003.08.003

reference URL

https://api.crossref.org/works/10.1016/J.BMC.2003.08.003

retrieved

29 March 2024

https://api.elsevier.com/content/article/PII:S0968089603005509?httpAccept=text/plain

1 reference

stated in

Crossref

DOI

10.1016/J.BMC.2003.08.003

reference URL

https://api.crossref.org/works/10.1016/J.BMC.2003.08.003

retrieved

29 March 2024

published in

Bioorganic & Medicinal Chemistry

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14604682

retrieved

5 December 2017

volume

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14604682

retrieved

5 December 2017

issue

23

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14604682

retrieved

5 December 2017

page(s)

5189-5198

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14604682

retrieved

5 December 2017

cites work

Increasing usage of systemic antifungal agents

series ordinal

1

1 reference

stated in

Crossref

DOI

10.1016/J.BMC.2003.08.003

reference URL

https://api.crossref.org/works/10.1016/J.BMC.2003.08.003

retrieved

29 March 2024

Limitations of current antimicrobial therapy in the immunosuppressed host: Looking at both sides of the coin

series ordinal

3

1 reference

stated in

Crossref

DOI

10.1016/J.BMC.2003.08.003

reference URL

https://api.crossref.org/works/10.1016/J.BMC.2003.08.003

retrieved

29 March 2024

Management of immunocompromised patients with evidence of an invasive mycosis.

series ordinal

5

1 reference

stated in

Crossref

DOI

10.1016/J.BMC.2003.08.003

reference URL

https://api.crossref.org/works/10.1016/J.BMC.2003.08.003

retrieved

29 March 2024

Fungal complications of transplantation: diagnosis, treatment and prevention

series ordinal

6

1 reference

stated in

Crossref

DOI

10.1016/J.BMC.2003.08.003

reference URL

https://api.crossref.org/works/10.1016/J.BMC.2003.08.003

retrieved

29 March 2024

Antifungal treatment strategy in leukemia patients

series ordinal

7

1 reference

stated in

Crossref

DOI

10.1016/J.BMC.2003.08.003

reference URL

https://api.crossref.org/works/10.1016/J.BMC.2003.08.003

retrieved

29 March 2024

Fungal infection in surgical patients

series ordinal

8

1 reference

stated in

Crossref

DOI

10.1016/J.BMC.2003.08.003

reference URL

https://api.crossref.org/works/10.1016/J.BMC.2003.08.003

retrieved

29 March 2024

Fluconazole resistant candida in AIDS.

series ordinal

13

1 reference

stated in

Crossref

DOI

10.1016/J.BMC.2003.08.003

reference URL

https://api.crossref.org/works/10.1016/J.BMC.2003.08.003

retrieved

29 March 2024

Fluconazole resistant candida in AIDS

series ordinal

14

1 reference

stated in

Crossref

DOI

10.1016/J.BMC.2003.08.003

reference URL

https://api.crossref.org/works/10.1016/J.BMC.2003.08.003

retrieved

29 March 2024

Fluconazole resistance in Candida glabrata

series ordinal

15

1 reference

stated in

Crossref

DOI

10.1016/J.BMC.2003.08.003

reference URL

https://api.crossref.org/works/10.1016/J.BMC.2003.08.003

retrieved

29 March 2024

Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters

series ordinal

16

1 reference

stated in

Crossref

DOI

10.1016/J.BMC.2003.08.003

reference URL

https://api.crossref.org/works/10.1016/J.BMC.2003.08.003

retrieved

29 March 2024

Importance of antifungal drug-resistance: clinical significance and need for novel therapy

series ordinal

17

1 reference

stated in

Crossref

DOI

10.1016/J.BMC.2003.08.003

reference URL

https://api.crossref.org/works/10.1016/J.BMC.2003.08.003

retrieved

29 March 2024

Semisynthetic Chemical Modification of the Antifungal Lipopeptide Echinocandin B (ECB): Structure-Activity Studies of the Lipophilic and Geometric Parameters of Polyarylated Acyl Analogs of ECB

series ordinal

18

1 reference

stated in

Crossref

DOI

10.1016/J.BMC.2003.08.003

reference URL

https://api.crossref.org/works/10.1016/J.BMC.2003.08.003

retrieved

29 March 2024

Pneumocandins from Zalerion arboricola. II. Modification of product spectrum by mutation and medium manipulation

series ordinal

19

1 reference

stated in

Crossref

DOI

10.1016/J.BMC.2003.08.003

reference URL

https://api.crossref.org/works/10.1016/J.BMC.2003.08.003

retrieved

29 March 2024

WF11899A, B and C, novel antifungal lipopeptides. II. Biological properties.

series ordinal

20

1 reference

stated in

Crossref

DOI

10.1016/J.BMC.2003.08.003

reference URL

https://api.crossref.org/works/10.1016/J.BMC.2003.08.003

retrieved

29 March 2024

Antibiotics that inhibit fungal cell wall development

series ordinal

21

1 reference

stated in

Crossref

DOI

10.1016/J.BMC.2003.08.003

reference URL

https://api.crossref.org/works/10.1016/J.BMC.2003.08.003

retrieved

29 March 2024

Recent advances in the epidemiology, prevention, diagnosis, and treatment of fungal pneumonia

series ordinal

22

1 reference

stated in

Crossref

DOI

10.1016/J.BMC.2003.08.003

reference URL

https://api.crossref.org/works/10.1016/J.BMC.2003.08.003

retrieved

29 March 2024

FK463, a novel water-soluble echinocandin lipopeptide: synthesis and antifungal activity

series ordinal

25

1 reference

stated in

Crossref

DOI

10.1016/J.BMC.2003.08.003

reference URL

https://api.crossref.org/works/10.1016/J.BMC.2003.08.003

retrieved

29 March 2024

Mulundocandin, a new lipopeptide antibiotic. I. Taxonomy, fermentation, isolation and characterization

series ordinal

26

1 reference

stated in

Crossref

DOI

10.1016/J.BMC.2003.08.003

reference URL

https://api.crossref.org/works/10.1016/J.BMC.2003.08.003

retrieved

29 March 2024

Synthesis and antifungal activity of novel cationic pneumocandin B(o) derivatives

series ordinal

41

1 reference

stated in

Crossref

DOI

10.1016/J.BMC.2003.08.003

reference URL

https://api.crossref.org/works/10.1016/J.BMC.2003.08.003

retrieved

29 March 2024

Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection

series ordinal

43

1 reference

stated in

Crossref

DOI

10.1016/J.BMC.2003.08.003

reference URL

https://api.crossref.org/works/10.1016/J.BMC.2003.08.003

retrieved

29 March 2024

Antifungal effects of the nonlinear pharmacokinetics of cilofungin, a 1,3-beta-glucan synthetase inhibitor, during continuous and intermittent intravenous infusions in treatment of experimental disseminated candidiasis

series ordinal

44

1 reference

stated in

Crossref

DOI

10.1016/J.BMC.2003.08.003

reference URL

https://api.crossref.org/works/10.1016/J.BMC.2003.08.003

retrieved

29 March 2024

Murine model of invasive pulmonary aspergillosis following an earlier stage, noninvasive Aspergillus infection.

series ordinal

45

1 reference

stated in

Crossref

DOI

10.1016/J.BMC.2003.08.003

reference URL

https://api.crossref.org/works/10.1016/J.BMC.2003.08.003

retrieved

29 March 2024

Comparative resistance of Candida albicans clinical isolates to fluconazole and itraconazole in vitro and in vivo in a murine model.

series ordinal

46

1 reference

stated in

Crossref

DOI

10.1016/J.BMC.2003.08.003

reference URL

https://api.crossref.org/works/10.1016/J.BMC.2003.08.003

retrieved

29 March 2024

In vitro antifungal activities and in vivo efficacies of 1,3-beta-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandin

series ordinal

47

1 reference

stated in

Crossref

DOI

10.1016/J.BMC.2003.08.003

reference URL

https://api.crossref.org/works/10.1016/J.BMC.2003.08.003

retrieved

29 March 2024

Identifiers

DOI

10.1016/J.BMC.2003.08.003

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14604682

retrieved

5 December 2017

PubMed publication ID

14604682

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14604682

retrieved

5 December 2017

ResearchGate publication ID

9019629

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44646726&oldid=2114019951"